Dr. Frits van Rhee is a Professor of Medicine and Clinical Director of the Myeloma Center at UAMS Myeloma Institute. Dr. van Rhee earned his medical degree from Erasmus University, Rotterdam, Netherlands and his PhD at the Imperial College of Science, Medicine and Technology, University of London. He trained in internal medicine and hematology in the UK, and in bone marrow transplantation at John Radcliffe University Hospital in Oxford and the Royal Postgraduate Medical School in London. Dr. van Rhee holds the Charles and Clydene Scharlau Chair for Hematological Malignancies.
He is an expert in multiple myeloma and other hematologic malignancies, with a research focus in immunotherapy. Dr. van Rhee is a member of the International Society for Cellular Therapy, the International Society for Experimental Hematology, the European Group for Bone and Marrow Transplantation, the Royal college of Physicians (UK), the Royal College of Pathologists (UK), and the American Society of Hematology. He has UK board certification in internal medicine and hematology.